Key result
Novel candidate treatments targeting emerging pathways offer potential to arrest and reverse PAH vascular pathology.
Why the study?
Current treatments for pulmonary arterial hypertension relieve symptoms and may slow progression but do not overcome the underlying vascular pathology, creating a need for treatments that arrest and reverse disease.
Answers are grounded in this paper and cite their sources.
This review highlights emerging therapeutic candidates targeting the underlying mechanisms of pulmonary arterial hypertension to arrest and reverse the condition.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wilkins et al. (2020) studied this question. Novel candidate treatments targeting emerging mechanistic pathways offer potential strategies to arrest and reverse the underlying vascular pathology of pulmonary arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: